BACKGROUND: Understanding tumor characteristics is likely important, but little is known about breast cancer patients' knowledge of their own disease. The authors assessed women's knowledge about their tumor characteristics, whether racial/ethnic disparities in knowledge exist, and whether education and health literacy influence associations. METHODS: A population-based cohort of women in Northern California with stage 0 through III breast cancers diagnosed from 2010 to 2011 (participation rate 68.5%) was surveyed. Among 500 respondents (222 non-Hispanic white women, 142 non-Hispanic black women, and 136 Hispanic women), racial/ethnic differences in knowledge about tumor characteristics (estrogen receptor [ER] status, human epidermal growth factor receptor 2 [HER2] status, stage, grade) and correctness of tumor information (with California Cancer Registry data for confirmation) were examined. Multivariate logistic regression was used to assess the probability of: 1) knowing tumor stage, receptor status, and grade; and 2) correctly answering questions about tumor information by race/ethnicity. The impact of education and health literacy on findings was examined in sequential models. RESULTS: Overall, 32% to 82% of women reported knowing each of the 4 tumor characteristics of interest, and 20% to 58% correctly reported these characteristics. After adjustment, black and Hispanic women were less likely than white women to know and have correct responses for stage, ER status, and HER2 status (all P<.05). Education and health literacy were significantly associated with knowing and having correct information about some characteristics, but these variables did not eliminate most of the racial/ethnic differences observed. CONCLUSIONS: Patient's knowledge about their own breast cancer was generally poor, particularly for minority women. Further study of how this knowledge may impact receipt of care and outcomes is warranted.
BACKGROUND: Understanding tumor characteristics is likely important, but little is known about breast cancer patients' knowledge of their own disease. The authors assessed women's knowledge about their tumor characteristics, whether racial/ethnic disparities in knowledge exist, and whether education and health literacy influence associations. METHODS: A population-based cohort of women in Northern California with stage 0 through III breast cancers diagnosed from 2010 to 2011 (participation rate 68.5%) was surveyed. Among 500 respondents (222 non-Hispanic white women, 142 non-Hispanic black women, and 136 Hispanic women), racial/ethnic differences in knowledge about tumor characteristics (estrogen receptor [ER] status, human epidermal growth factor receptor 2 [HER2] status, stage, grade) and correctness of tumor information (with California Cancer Registry data for confirmation) were examined. Multivariate logistic regression was used to assess the probability of: 1) knowing tumor stage, receptor status, and grade; and 2) correctly answering questions about tumor information by race/ethnicity. The impact of education and health literacy on findings was examined in sequential models. RESULTS: Overall, 32% to 82% of women reported knowing each of the 4 tumor characteristics of interest, and 20% to 58% correctly reported these characteristics. After adjustment, black and Hispanic women were less likely than white women to know and have correct responses for stage, ER status, and HER2 status (all P<.05). Education and health literacy were significantly associated with knowing and having correct information about some characteristics, but these variables did not eliminate most of the racial/ethnic differences observed. CONCLUSIONS: Patient's knowledge about their own breast cancer was generally poor, particularly for minority women. Further study of how this knowledge may impact receipt of care and outcomes is warranted.
Authors: Jennifer L Malin; Katherine L Kahn; John Adams; Lorna Kwan; Marianne Laouri; Patricia A Ganz Journal: J Natl Cancer Inst Date: 2002-06-05 Impact factor: 13.506
Authors: Angela Fagerlin; Indu Lakhani; Paula M Lantz; Nancy K Janz; Monica Morrow; Kendra Schwartz; Dennis Deapen; Barbara Salem; Lihua Liu; Steven J Katz Journal: Patient Educ Couns Date: 2006-07-24
Authors: Lisa D Chew; Joan M Griffin; Melissa R Partin; Siamak Noorbaloochi; Joseph P Grill; Annamay Snyder; Katharine A Bradley; Sean M Nugent; Alisha D Baines; Michelle Vanryn Journal: J Gen Intern Med Date: 2008-03-12 Impact factor: 5.128
Authors: Tinuke O Olagunju; Yihang Liu; Li-Jung Liang; James M Stomber; Jennifer J Griggs; Patricia A Ganz; Amardeep Thind; Rose C Maly Journal: Cancer Date: 2018-04-06 Impact factor: 6.860
Authors: Kaleea Lewis; Shibani Kulkarni; Swann Arp Adams; Heather M Brandt; Jamie R Lead; John R Ureda; Delores Fedrick; Chris Mathews; Daniela B Friedman Journal: Environ Int Date: 2018-09-06 Impact factor: 9.621
Authors: Megan C Edmonds; Arnethea L Sutton; Jun He; Robert A Perera; Vanessa B Sheppard Journal: J Natl Med Assoc Date: 2020-03-18 Impact factor: 1.798
Authors: Sidra N Bonner; Cheryl Clark; Nancy L Keating; Elena M Kouri; Rachel A Freedman Journal: Clin Breast Cancer Date: 2018-12-08 Impact factor: 3.225
Authors: Barbara J Turner; Yuanyuan Liang; Natalia Rodriguez; Melissa A Valerio; Andrea Rochat; Jennifer S Potter; Paula Winkler Journal: J Pain Date: 2017-01-12 Impact factor: 5.820
Authors: Rachel A Freedman; Elena M Kouri; Dee W West; Shoshana Rosenberg; Ann H Partridge; Joyce Lii; Nancy L Keating Journal: Clin Breast Cancer Date: 2015-08-28 Impact factor: 3.078